Acid Reflux & Heartburn

Acid Reflux & Heartburn: A Comprehensive Nutrition and Natural Health Reference

1. Definition and Overview

Gastroesophageal reflux disease (GERD) is a condition in which there is retrograde flow of gastric contents into the esophagus or beyond into the oral cavity, larynx, or lungs, resulting in esophagitis and inflammation of other affected mucosal surfaces. The American College of Gastroenterology (ACG) defines GERD as chronic symptoms or mucosal damage incurred by the abnormal reflux of gastric contents into the esophagus and beyond. GERD is a chronic condition; once it begins, it is usually life-long.

GERD is generally defined as a chronic relapsing condition in which the reflux of stomach content into the oesophagus and beyond provokes symptoms and/or complications. The regurgitated liquid usually contains acid and pepsin that are produced by the stomach, and it may also contain bile that has backed up into the stomach from the duodenum. Acid is believed to be the most injurious component of the refluxed liquid; pepsin and bile may also injure the esophagus, but their role in producing esophageal inflammation and damage (esophagitis) is not as clear as that of acid.

The global pooled prevalence of GERD is approximately 13.98%, varying greatly by region — from 12.88% in Latin America and the Caribbean to 19.55% in North America — and by country, ranging from 4.16% in China to 22.40% in Turkey. A global population-based study showed a prevalence of 13% for at least one episode of GERD symptoms per week, and the global combined prevalence of GERD in all regions has increased since 1995, especially in North America (18.1%–27.8%) and East Asia (2.5%–7.8%).

2. Presentation and Symptoms

The regurgitation is referred to as "heartburn" because the most common symptom is a burning discomfort in the chest under the breastbone. Burning discomfort in the chest and regurgitation of sour-tasting gastric juice into the mouth are classic symptoms of GERD.

Reflux esophagitis secondary to GERD is typically classified as nonerosive reflux disease (NERD) with symptoms, or symptomatic disease with esophageal erosions, termed erosive reflux disease. Although reflux esophagitis is generally more common in men, NERD is more prevalent in women.

Dyspepsia, defined as epigastric discomfort without heartburn or acid regurgitation lasting longer than one month, can be associated with bloating/epigastric fullness, belching, nausea, and vomiting, and is considered a distinct entity from GERD.

3. Body Systems Involved

3.1 The Gastrointestinal Tract

The pathogenesis of GERD is complex and involves changes in reflux exposure, epithelial resistance, and visceral sensitivity. The mechanisms involved in the pathogenesis of GERD are multiple and include: motor abnormalities, such as impaired lower oesophageal sphincter (LES) resting tone, transient LES relaxations (TLESR), impaired oesophageal acid clearance and delayed gastric emptying; anatomical factors, such as hiatal hernia; visceral hypersensitivity; and impaired mucosal resistance.

The most common cause is transient lower esophageal sphincter relaxations (TLESRs) — brief moments of lower esophageal sphincter tone inhibition that are independent of a swallow. While these are physiologic in nature, there is an increase in frequency in the postprandial phase, and they contribute greatly to acid reflux in patients with GERD.

A hiatal hernia disturbs the anatomical relationship between the crural diaphragm and the lower esophageal sphincter function. Hernias can act as a reservoir for gastric contents, which can reflux into the esophagus when the lower esophageal sphincter relaxes.

Peristaltic dysfunction is an important contributor to severity of esophagitis. The level of acid exposure has been directly linked to the degree of ineffective or weak peristalsis; the classic threshold for an effective contraction associated with intact bolus clearance is an amplitude of more than 30 mmHg.

Esophageal submucosal glands secrete bicarbonate and mucin to protect the distal esophageal mucosa from acidic stomach contents.

3.2 Extra-Esophageal and Systemic Involvement

Some people with GERD may develop recurrent pneumonia, asthma (wheezing), or a chronic cough from acid backing up into the esophagus and through the upper esophageal sphincter into the lungs. Some people with GERD develop complications outside the esophagus, in the mouth, throat, or lungs.

A 2025 meta-analysis of six cohort studies (1,324,362 participants) found that patients with GERD had a 27% increased risk of incident acute myocardial infarction (pooled RR: 1.27, 95% CI: 1.13–1.47), with potential mechanisms including chronic inflammation, oxidative stress, and autonomic dysfunction.

4. Complications

Left untreated, GERD can result in several serious complications, including esophagitis and Barrett's esophagus. Esophagitis can vary widely in severity, with severe cases resulting in extensive erosions, ulcerations, and narrowing of the esophagus. Upper GI bleeding may present as anemia, hematemesis, coffee-ground emesis, or melena.

In Barrett's esophagus, the normal squamous cell epithelium of the esophagus is replaced by columnar epithelium with goblet cells, as a response to acid exposure. Changes of Barrett's esophagus may extend proximally from the gastroesophageal junction and have the potential to progress to esophageal adenocarcinoma, making early detection important in the prevention and management of malignant transformation.

Having GERD increases the chances of developing Barrett's esophagus; researchers estimate approximately 5% to 15% of people with GERD go on to develop this condition. Barrett's esophagus predisposes patients to developing dysplasia and esophageal adenocarcinoma, a cancer with high morbidity and mortality that has been increasing in incidence over the past 50 years.

5. Contributing and Associated Factors

5.1 Physiological and Anatomical Factors

Esophageal exposure to gastric refluxate is the primary determinant of disease severity. This exposure arises via compromise of the anti-reflux barrier and reduced ability of the esophagus to clear and buffer the refluxate. However, complications and symptoms also occur in the context of normal reflux burden, when there is either poor epithelial resistance or increased visceral sensitivity.

From a pathophysiological point of view, changes in the anatomy of the stomach and esophagus that may be caused by obesity are closely related to the development of GERD: anti-reflux barrier defects such as LES dysfunction, transient lower esophageal sphincter relaxation, and hiatal hernia, as well as impaired esophageal clearance function, including reduced salivary secretion, impaired esophageal motility, transdiaphragmatic pressure gradient, and prolonged gastric emptying time, are more common in obese patients. In addition, abnormal serum levels of cytokines such as leptin and adiponectin in obese patients may also contribute to the increased risk of GERD.

5.2 Lifestyle, Demographic, and Behavioral Factors

Risk factors for GERD include older age, excessive body mass index (BMI), smoking, anxiety/depression, and less physical activity at work. Eating habits may also contribute to GERD, including the acidity of food, as well as size and timing of meals, particularly with respect to sleep. Recreational physical activity appears to be protective, except when performed post-prandially.

An interval of less than three hours between dinner and bedtime (OR = 7.45, 95% CI 3.38–16.4) was positively related to GERD, and proper physical exercise (greater than 30 minutes, more than 3 times per week) was negatively correlated with GERD (OR = 0.7, 95% CI 0.6–0.9).

Smoking (OR = 1.19, 95% CI 1.12–1.264), alcohol consumption (OR = 1.278, 95% CI 1.207–1.353), and poor mental state (OR = 1.278, 95% CI 1.207–1.353) were positively correlated with GERD.

Fatty, fried, sour, and spicy foods; orange and grapefruit juice; tomatoes and canned tomatoes; chocolate; coffee/tea; carbonated beverages; and alcohol are considered among the main triggers for GERD symptoms, according to review literature.

5.3 Sleep and Circadian Factors

GERD is known to have an association with sleep disturbance. Poor quality of sleep is one of the risk factors for GERD symptoms, and nocturnal symptoms such as night-time heartburn further lower the quality of sleep and make it difficult to fall asleep.

5.4 Dietary Fiber Intake

The available evidence suggests a positive correlation between quantities of dietary fiber in the patient's diet and GERD manifestations. Key features of pathogenesis caused by lack of nutritional fiber include slow gastric emptying, increased gastric volume, increased risk of obesity and hiatal hernia, and reduced lower esophageal sphincter pressure. Epidemiological studies suggest a higher incidence of GERD symptoms, higher prevalence of Barrett's esophagus, and higher prevalence of esophageal adenocarcinoma in patients who consume low quantities of nutritional fiber.

6. Nutrients, Herbs, and Natural Ingredients

6.1 Marine Alginate

Traditional Use: Raft-forming agents such as alginate, pectin, and carbenoxolone provide a non-systemic treatment strategy for GERD by creating protective barriers that inhibit acid reflux. Alginate is a natural polymer derived from algae that serves as the primary component in many such formulations.

Scientific Evidence: In GERD therapy, alginate produces a gel raft that inhibits acid reflux, providing an effective alternative to proton pump inhibitors. Alginate-based products have demonstrated clinical success. Melatonin and marine alginate appear promising for GERD use; a comprehensive systematic review assessing the current body of evidence for melatonin, and additional trials investigating marine alginate against a placebo, would be helpful to determine their effectiveness and the appropriate dose for each. A 2025 real-world evidence study in India (PMC11965474) evaluated sodium alginate antacid suspension (10–20 mL, 3–4 times daily) in GERD patients, and a 2025 randomized controlled trial published in Scientific Reports examined generic versus original alginate formulations in PPI-refractory GERD. At day 7, both groups showed identical response rates of 45.83%; by day 28, response rates were 54.17% for generic alginate and 70.83% for original alginate (p = 0.23), with no statistically significant difference. Evidence for alginate is among the most robust for a natural ingredient in GERD, though most trials are sponsored by or compare against pharmaceutical formulations.

6.2 Melatonin

Traditional/Physiological Context: Melatonin generated in the gastrointestinal tract has a mucosal protective effect by inhibiting gastric acid secretion while increasing gastrin release, which in turn stimulates the contractility of the lower esophageal sphincter. Melatonin is an endogenous hormone produced from tryptophan in the brain and has a range of physiological effects, the primary one being to regulate circadian rhythms.

Scientific Evidence: A small RCT (36 subjects, 4 groups) found that melatonin plays a role in the improvement of GERD when used alone or in combination with omeprazole. Omeprazole alone was found more effective than melatonin alone. The study concluded oral melatonin is a promising therapeutic agent, effective in relieving epigastric pain and heartburn, but further studies are required to confirm efficacy and long-term safety before routine clinical use is recommended.

A 2023 randomized, double-blind clinical trial investigated whether the addition of sublingual melatonin to omeprazole was effective in treating GERD symptoms. A total of 78 patients were randomly allocated to either omeprazole 20 mg/day plus sublingual melatonin (3 mg/day), or omeprazole alone. The combination of sublingual melatonin (3 mg/day) with omeprazole (20 mg/day) may be more effective than omeprazole (20 mg/day) alone in the treatment of GERD. Overall, evidence for melatonin in GERD is preliminary-to-moderate in strength; trials are generally small, and a comprehensive meta-analysis remains to be completed as of the protocol stage.

6.3 Aloe Vera (Aloe barbadensis)

Traditional Use: Aloe vera has traditionally been used due to its soothing effects on the digestive system, and consuming small amounts of pure aloe vera juice before meals may reduce acid reflux symptoms.

Scientific Evidence: In a 2015 open-label RCT, participants (n = 79) took either aloe vera syrup (10 mL once daily, standardized to 5.0 mg of polysaccharides per mL), ranitidine (150 mg twice daily), or omeprazole (20 mg once daily). Aloe vera was slightly less effective in symptom relief compared to ranitidine and omeprazole, though it was well-tolerated. Latex-free aloe products are recommended for GERD management to avoid the potent laxative effects of anthraquinones, concentrated in the latex of the outer leaf layer.

Aloe vera was safe and well tolerated and reduced the frequencies of all assessed GERD symptoms, but nephrotoxicity and hepatotoxicity concerns (and its classification as a possible human carcinogen, Group 2B, when containing anthraquinones) have kept its use in a controversial position. Aloe vera is represented in a handful of trials but mostly in combinatorial form; further investigation in isolation would help elucidate its specific effects. Evidence is preliminary and limited to small pilot trials.

6.4 Licorice Root and Deglycyrrhizinated Licorice (DGL)

Traditional Use: Licorice root, obtained from Glycyrrhiza glabra or Glycyrrhiza uralensis, has been historically applied to treat gastrointestinal disorders due to its demulcent properties. The plant is believed to increase mucus secretion and protect the esophageal lining against irritation. The therapeutic actions are believed to be facilitated by the principal active constituents — triterpenoid saponins and flavonoids.

Traditional Preparations and Deglycyrrhizination: Whole licorice root contains glycyrrhizin, which at high or prolonged doses can cause pseudohyperaldosteronism, hypertension, and hypokalemia. For long-term use, licorice is prescribed as deglycyrrhizinated licorice (DGL) in order to avoid these side effects. Patients sometimes take DGL, chamomile, slippery elm, marshmallow root, D-limonene, and/or betaine — products that are part of the herbal and naturopathic medicine traditions for GERD treatment; however, there are no rigorous studies evaluating their individual efficacy. Evidence for DGL specifically in GERD remains at the level of traditional use without robust controlled trial data.

6.5 Ginger (Zingiber officinale)

Traditional Use: Ginger has a longstanding history of use across Asian, Ayurvedic, and Western herbal traditions for nausea, dyspepsia, and stomach upset. Ginger, among other natural products, is used in traditional practices to enhance lower esophageal sphincter function, decrease gastric acid secretion, and protect the esophageal lining.

Scientific Evidence: Ginger's anti-inflammatory and antioxidant components, especially gingerols and shogaols, are the focus of preclinical investigation in GERD models. Those nutritional ingredients with the most robust human evidence in upper GI conditions include ginger — principally for pregnancy-induced nausea and vomiting — and peppermint and caraway oil for functional dyspepsia. Ginger's specific evidence base for GERD (as opposed to nausea or dyspepsia) is limited; most data derive from in vitro studies or as a component of multi-ingredient preparations, making it difficult to determine isolated effects on acid reflux.

6.6 Slippery Elm (Ulmus rubra)

Traditional Use: Slippery elm has been used by Native Americans to treat various ailments including gastrointestinal-related problems. Marshmallow root and slippery elm contain mucilage, which can form a gel-like coating on the esophageal lining, acting as a barrier against acid and reducing discomfort and inflammation.

Scientific Evidence: Slippery elm has little or no clinical evidence of its efficacy in treating GERD; clinical trials or studies for slippery elm for GERD are limited, if any. While slippery elm is commonly suggested for managing GERD symptoms due to its mucilaginous properties, clinical evidence specifically supporting its effectiveness for GERD is limited. The Cochrane Database of Systematic Reviews highlights a scarcity of robust studies on slippery elm's efficacy for GERD, suggesting that its effectiveness may not be firmly established. Evidence is restricted to traditional use and a small number of combination product studies.

6.7 Marshmallow Root (Althaea officinalis)

Traditional Use: Marshmallow root is used in European herbal traditions and documented in the naturopathic literature as a demulcent for gastric and esophageal irritation. Herbs such as licorice, slippery elm, and marshmallow root enhance mucosal defense by stimulating mucus production. Anti-inflammatory herbs such as chamomile help reduce esophageal irritation and support tissue repair.

Scientific Evidence: Like slippery elm, marshmallow root's use in GERD is rooted primarily in the traditional and naturopathic literature. DGL, chamomile, slippery elm, marshmallow root, D-limonene, and betaine are part of the herbal and naturopathic medicine traditions for GERD treatment; however, there are no rigorous studies evaluating their efficacy. Clinical trial evidence specific to GERD does not yet exist at the level required to characterize evidence strength beyond traditional use.

6.8 Chamomile (Matricaria chamomilla)

Traditional Use: Chamomile is used as an anti-inflammatory herb in traditions addressing gastric and esophageal complaints. It has been incorporated in traditional European phytotherapy for gastric spasm and mucosal inflammation.

Scientific Evidence: Clinical evidence isolating chamomile's effects on GERD specifically is absent. It appears primarily in multi-ingredient formulations. Evidence is at the traditional/observational level only.

6.9 Probiotics

Traditional/Nutritional Context: Yogurt, when not too sour, is considered beneficial for acid reflux due to its probiotics, which aid in normalizing bowel function.

Scientific Evidence: A systematic review on the efficacy of probiotics in alleviating the frequency and severity of symptoms in GERD searched PubMed and Web of Science for prospective studies. In total, 13 prospective studies (12 articles) were included, and 11 (79%) reported positive benefits of probiotics on GERD symptoms. Although probiotics do not eradicate H. pylori, they have been shown to reduce its activity. For B. bifidum YIT 10347, four intervention trials indicated positive changes in symptom scores; for other strains, too few studies were available to draw overall conclusions. Evidence is emerging and promising but heterogeneous, with most trials rated as low-to-medium quality; further high-quality RCTs are needed.

6.10 D-Limonene

Traditional/Nutritional Context: D-limonene is the principal component of citrus peel oil and has been considered a folk remedy for heartburn. It is listed in the naturopathic medicine literature as used for GERD.

Scientific Evidence: D-limonene is reviewed among "other" botanical ingredients with limited evidence, or those subject to trials outside standard inclusion-date ranges. Available clinical data are very limited and primarily uncontrolled; the evidence is insufficient to make any characterization of efficacy.

6.11 Dietary Fiber Supplements (Including Fenugreek/Galactomannan)

Scientific Evidence: An RCT comparing a dietary fiber product (n = 15) with placebo (n = 15) for two weeks showed an increased number of days without heartburn (mean 1.87 versus 0.73, P < 0.05) and a reduced severity score (mean 7.7 versus 13.3, P < 0.05) in the fiber group. Fenugreek, galactomannan, and zinc-L-carnosine represent promising areas for further study. These findings are preliminary and come from small, short-duration trials.

7. Dietary Factors

7.1 Trigger Foods

Fatty, fried, sour, and spicy foods; orange and grapefruit juice; tomatoes and canned tomatoes; chocolate; coffee/tea; carbonated beverages; and alcohol are considered the main dietary triggers for GERD symptoms, based on review literature. While several observational studies have suggested avoidance of certain foods and recommended alternative diets (such as Mediterranean, low-carbohydrate, and fiber-rich diets), high-quality evidence such as a well-designed RCT is lacking. The strength of the recommendation to avoid trigger foods or beverages is characterized as Grade C (low). Alcohol and tobacco consumption have been directly implicated in triggering GERD symptoms.

7.2 Mediterranean Diet

A 2016 study found that following the Mediterranean diet, which is rich in fruits, vegetables, whole grains, and unsaturated fats, was linked with a lower risk of GERD. This is observational evidence; prospective trials with dietary pattern interventions specific to GERD are limited.

7.3 Dietary Fiber

The main features of GERD pathogenesis associated with lack of nutritional fiber include slow gastric emptying, increased gastric volume, increased risk of obesity and hiatal hernia, and reduced lower esophageal sphincter pressure. Both epidemiological data and small RCTs support dietary fiber's inverse association with GERD, but trials are small and of short duration.

7.4 Carbonated Beverages

A systematic review based on observational studies showed no evidence of carbonated beverages directly promoting GERD. This finding is counterintuitive relative to common advice, and the evidence base is observational rather than interventional.

7.5 Meal Timing

A crossover RCT of 30 patients randomized to a late meal (2 hours before bedtime) or an early meal (6 hours before bedtime) showed more pH-verified supine reflux after the late evening meal (mean change 5.2%, P = 0.002). The American College of Gastroenterology guideline supports avoidance of meals 2 to 3 hours before bedtime, in addition to weight loss and head-of-bed elevation.

8. Lifestyle Factors

8.1 Weight Loss

Weight loss was followed by decreased time with esophageal acid exposure in 2 RCTs (from 5.6% to 3.7% and from 8.0% to 5.5%), and reduced reflux symptoms in prospective observational studies. Weight loss could lead to the resolution of GERD; conservative measures including dietary modifications and weight loss should be considered as first-line management for GERD, particularly in obese patients.

8.2 Head-of-Bed Elevation

A crossover RCT of 15 GERD participants showed that elevation of the head of the bed by a 10-inch wedge decreased esophageal pH less-than-4 time compared to a flat position (15% versus 21%, P < 0.05). A systematic review of five trials (228 patients) found that all five included trials were at high risk of performance bias and four of selection bias; nonetheless, the four studies reporting on GERD symptoms found an improvement among participants with head-of-bed elevation, and a high-quality crossover trial showed a clinically important reduction in symptom scores.

8.3 Smoking Cessation

Tobacco smoking cessation reduced reflux symptoms in normal-weight individuals in a large prospective cohort study (odds ratio, 5.67). This finding applies specifically to normal-weight individuals; the evidence in overweight or obese individuals is less clear in isolation.

8.4 Physical Activity

Recreational physical activity appears protective against GERD, except when performed post-prandially. Mechanically, regular physical activity is associated with weight management and reduced intra-abdominal pressure, both recognized risk-modifying factors for GERD.

8.5 Alcohol and Tobacco

Smoking (OR = 1.19, 95% CI 1.12–1.264) and alcohol consumption (OR = 1.278, 95% CI 1.207–1.353) were positively correlated with GERD across studies. Alcohol and tobacco consumption have been directly implicated in triggering GERD symptoms.

References

• Savarino V et al. Pathophysiology of gastro-oesophageal reflux disease. Acta Biomed. 2006. PMC2639970
• Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease (GERD). JAMA. 2020. PMC6140167
• Gyawali CP, Kahrilas PJ, Savarino E, et al. Pathophysiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018. PubMed 29037470
• Gyawali CP, Kahrilas PJ et al. Pathophysiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018.
• Antunes C, Aleem A, Curtis SA. Gastroesophageal Reflux Disease. StatPearls. NCBI Bookshelf. 2025.
• Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global Prevalence and Risk Factors of GERD: Systematic Review with Meta-analysis. Scientific Reports. 2020.
• Anebo T et al. GERD and Risk of Incident Acute Myocardial Infarction: A Systematic Review and Meta-Analysis. JGH Open. 2025. PMC12518159
• Liu L et al. Dietary and Lifestyle Factors Related to GERD. Ther Clin Risk Manag. 2021. Dove Medical Press.
• Risk Factors for GERD: A Population-Based Study. PMC10840240.
• BMI and Risk of GERD: A Systematic Review with Dose-Response Meta-analysis. PMC12689342.
• NIDDK. Definition & Facts for GER & GERD. National Institute of Diabetes and Digestive and Kidney Diseases.
• NIDDK. Symptoms & Causes of Barrett's Esophagus.
• Spechler SJ. Barrett Esophagus. StatPearls. NCBI Bookshelf. 2025.
• Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2016. PMC4636482
• Ness-Jensen E et al. Lifestyle Intervention in Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology. 2016.
• Role of Non-pharmacological Interventions and Weight Loss in the Management of GERD in Obese Individuals. PMC9524852.
• Albarqouni L et al. Head of bed elevation to relieve GERD symptoms: a systematic review. BMC Fam Pract. 2021. PMC7816499
• Morozov S et al. The role of nutritional fiber deficiency in the pathogenesis and course of GERD. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2024.
• Natural Products in the Management of GERD: Mechanisms, Efficacy, and Future Directions. Nutrients. 2025. PMC11944625
• Martin Z, Spry G, Hoult J, et al. Effectiveness of Nutritional Ingredients on Upper Gastrointestinal Conditions and Symptoms: A Narrative Review. Nutrients. 2022.
• Kandil TS et al. The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease. BMC Gastroenterol. 2010. PMC2821302
• Malekpour H et al. Is the Addition of Sublingual Melatonin to Omeprazole Superior to Omeprazole Alone in the Management of GERD: A Clinical Trial. Turk J Gastroenterol. 2023. PMC10765200
• Melatonin for the Treatment of GERD: Protocol for a Systematic Review and Meta-Analysis. PMC6358381.
• Cheng J, Ouwehand AC. Gastroesophageal Reflux Disease and Probiotics: A Systematic Review. Nutrients. 2020. PMC7019778
• Functional Food in Relation to Gastroesophageal Reflux Disease (GERD). PMC10458865.
• Kligler B et al. Integrative Medicine for Gastrointestinal Disease. Prim Care. 2017. PMC5605819
• Alternative Treatments for Minor GI Ailments. PMC8127090.
• Chandrasekhara TS et al. Rapid Relief of GERD Symptoms with Sodium Alginate Antacid Suspension: An Indian Real-World Evidence Study. Cureus. 2025. PMC11965474
• Tangvoraphonkchai K et al. Comparable Efficacy of Generic and Original Alginate for Symptom Control in PPI-Refractory GERD. Sci Rep. 2025.
• Kröner PT, Cortés P, Lukens FJ. The Medical Management of GERD: A Narrative Review. 2021.